Freire Salinas Ana

Director · Spanish companies register · 2 companies

Companies :
2 (1 current, 1 former)
Linked companies :
ARDENA PAMPLONA SL, 3 P BIOPHARMACEUTICALS SL

Summary

Freire Salinas Ana appears in the Spanish commercial register as a director of 2 companies, 1 current and 1 former. Currently Apoderado of ARDENA PAMPLONA SL (Navarra) since 12 December 2019. ARDENA PAMPLONA SL is based in Noain, Valle de Elorz/Noain, Elortzibar and operates in Fabricación de especialidades farmacéuticas (CNAE 2120) — Sociedad Limitada (SL), an active company, share capital of €2,684,050. The earliest registered mandate dates from 30 June 2015, at 3 P BIOPHARMACEUTICALS SL; the most recent began on 12 December 2019. The companies are registered in Navarra. The boards of these companies also include De Ganck Ariane Elise, Everaert Arnout Marc, De la Haza de Lara Luis and 1 other.

Offices held

Apoderado

Commercial registries

Navarra

Companies · current (1)

Apoderado since 12/12/2019

Active · Fabricación de especialidades farmacéuticas (CNAE 2120) · Noain, Valle de Elorz/Noain, Elortzibar · Sociedad Limitada (SL) · capital €2,684,050 · 38 BORME filings

B31732399 · Navarra

Companies · former (1)

Former Apoderado · from 30/06/2015 to 14/05/2021

Active · Fabricación de productos farmacéuticos de base (CNAE 2110) · Noain, Valle de Elorz/Noain, Elortzibar · Sociedad Limitada (SL) · capital €8,382,220 · 72 BORME filings

B31875800 · Navarra

Timeline (4)

  1. 14/05/2021Ceased as Apoderado of 3 P BIOPHARMACEUTICALS SL · Navarra
  2. 12/12/2019Appointed Apoderado of ARDENA PAMPLONA SL · Navarra
  3. 03/05/2019Ceased as Apoderado of 3 P BIOPHARMACEUTICALS SL · Navarra
  4. 30/06/2015Appointed Apoderado of 3 P BIOPHARMACEUTICALS SL · Navarra

Co-directors (4)

Network map

5 nodes Person Company
freire-salinas-anaARDENA PAMPLONA SLARDENA PAMPLONA SLDE GANCK ARIANE ELISEDE GANCK ARIANE ELISEEVERAERT ARNOUT MARCEVERAERT ARNOUT MARCDE LA HAZA DE LARA LUISDE LA HAZA DE LARA L…

Identity matched by name · homonyms possible.